BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25904005)

  • 21. Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.
    Hsieh MH; Ho SC; Yeh KY; Pawlak CR; Chang HM; Ho YJ; Lai TJ; Wu FY
    Pharmacol Biochem Behav; 2012 Jul; 102(1):64-71. PubMed ID: 22487770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats.
    Chen L; Liu J; Ali U; Gui ZH; Wang Y; Wang T; Hou C; Fan LL
    Chin J Physiol; 2011 Oct; 54(5):303-9. PubMed ID: 22135908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
    Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
    Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of metabotropic glutamate receptor 5 induces cellular stress through pertussis toxin-sensitive Gi-proteins in murine BV-2 microglia cells.
    Chantong B; Kratschmar DV; Lister A; Odermatt A
    J Neuroinflammation; 2014 Nov; 11():190. PubMed ID: 25407356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
    De Leonibus E; Managò F; Giordani F; Petrosino F; Lopez S; Oliverio A; Amalric M; Mele A
    Neuropsychopharmacology; 2009 Feb; 34(3):729-38. PubMed ID: 18704096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
    Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
    Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Wang S; Hu LF; Zhang Y; Sun T; Sun YH; Liu SY; Ding JH; Wu J; Hu G
    Neuropsychopharmacology; 2006 May; 31(5):933-40. PubMed ID: 16123757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
    Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
    J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin mediates protection of hydrogen sulfide against 6-hydroxydopamine-induced Parkinson's disease: Involving enhancement in Warburg effect.
    Yang SQ; Tian Q; Li D; He SQ; Hu M; Liu SY; Zou W; Chen YJ; Zhang P; Tang XQ
    Neurochem Int; 2020 May; 135():104692. PubMed ID: 32032636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes.
    Singh S; Mishra A; Mishra SK; Shukla S
    Neurochem Int; 2017 Sep; 108():388-396. PubMed ID: 28577987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.
    Chen HH; Lin SC; Chan MH
    Neurodegener Dis; 2011; 8(5):364-74. PubMed ID: 21494012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice.
    Richter F; Hamann M; Richter A
    Brain Res; 2008 Jan; 1188():148-56. PubMed ID: 18035334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
    Marques NF; Massari CM; Tasca CI
    Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.
    Armentero MT; Levandis G; Bazzini E; Cerri S; Ghezzi C; Blandini F
    Neurobiol Dis; 2011 Sep; 43(3):663-8. PubMed ID: 21684338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker.
    Coune PG; Craveiro M; Gaugler MN; Mlynárik V; Schneider BL; Aebischer P; Gruetter R
    NMR Biomed; 2013 Jan; 26(1):43-50. PubMed ID: 22711560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson's disease.
    Iravanpour F; Dargahi L; Rezaei M; Haghani M; Heidari R; Valian N; Ahmadiani A
    CNS Neurosci Ther; 2021 Mar; 27(3):308-319. PubMed ID: 33497031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.